annual EBIT:
$11.56M+$129.55M(+109.80%)Summary
- As of today (May 29, 2025), BCRX annual earnings before interest & taxes is $11.56 million, with the most recent change of +$129.55 million (+109.80%) on December 31, 2024.
- During the last 3 years, BCRX annual EBIT has risen by +$134.08 million (+109.44%).
- BCRX annual EBIT is now at all-time high.
Performance
BCRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$24.25M+$25.79M(+1672.76%)Summary
- As of today (May 29, 2025), BCRX quarterly earnings before interest & taxes is $24.25 million, with the most recent change of +$25.79 million (+1672.76%) on March 31, 2025.
- Over the past year, BCRX quarterly EBIT has increased by +$34.76 million (+330.80%).
- BCRX quarterly EBIT is now at all-time high.
Performance
BCRX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$46.32M+$34.76M(+300.64%)Summary
- As of today (May 29, 2025), BCRX TTM earnings before interest & taxes is $46.32 million, with the most recent change of +$34.76 million (+300.64%) on March 31, 2025.
- Over the past year, BCRX TTM EBIT has increased by +$149.55 million (+144.87%).
- BCRX TTM EBIT is now at all-time high.
Performance
BCRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BCRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +109.8% | +330.8% | +144.9% |
| 3 y3 years | +109.4% | +148.4% | +138.2% |
| 5 y5 years | +111.9% | +170.2% | +144.9% |
BCRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +108.0% | at high | +148.4% | at high | +131.9% |
| 5 y | 5-year | at high | +106.9% | at high | +144.2% | at high | +125.1% |
| alltime | all time | at high | +106.9% | at high | +144.2% | at high | +125.1% |
BCRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $24.25M(-1672.8%) | $46.32M(+300.6%) |
| Dec 2024 | $11.56M(-109.8%) | -$1.54M(-113.5%) | $11.56M(-145.4%) |
| Sep 2024 | - | $11.38M(-6.9%) | -$25.48M(-43.8%) |
| Jun 2024 | - | $12.23M(-216.4%) | -$45.33M(-56.1%) |
| Mar 2024 | - | -$10.51M(-72.8%) | -$103.23M(-12.5%) |
| Dec 2023 | -$117.99M(-18.8%) | -$38.58M(+355.3%) | -$117.99M(-5.2%) |
| Sep 2023 | - | -$8.47M(-81.4%) | -$124.42M(-5.9%) |
| Jun 2023 | - | -$45.67M(+80.8%) | -$132.17M(+9.7%) |
| Mar 2023 | - | -$25.27M(-43.9%) | -$120.48M(-17.1%) |
| Dec 2022 | -$145.29M(+18.6%) | -$45.01M(+177.4%) | -$145.29M(+49.7%) |
| Sep 2022 | - | -$16.22M(-52.3%) | -$97.03M(-22.7%) |
| Jun 2022 | - | -$33.98M(-32.1%) | -$125.49M(+3.5%) |
| Mar 2022 | - | -$50.08M(-1639.0%) | -$121.22M(-1.1%) |
| Dec 2021 | -$122.52M(-27.2%) | $3.25M(-107.3%) | -$122.52M(-32.2%) |
| Sep 2021 | - | -$44.69M(+50.4%) | -$180.65M(+1.0%) |
| Jun 2021 | - | -$29.70M(-42.2%) | -$178.84M(-3.2%) |
| Mar 2021 | - | -$51.38M(-6.4%) | -$184.83M(+10.0%) |
| Dec 2020 | -$168.31M(+73.5%) | -$54.88M(+28.0%) | -$168.00M(+49.1%) |
| Sep 2020 | - | -$42.88M(+20.1%) | -$112.65M(+8.0%) |
| Jun 2020 | - | -$35.69M(+3.3%) | -$104.32M(+1.1%) |
| Mar 2020 | - | -$34.55M(-7530.5%) | -$103.23M(+6.4%) |
| Dec 2019 | -$97.00M(+5.4%) | $465.00K(-101.3%) | -$97.00M(-20.8%) |
| Sep 2019 | - | -$34.55M(-0.1%) | -$122.49M(+6.3%) |
| Jun 2019 | - | -$34.59M(+22.1%) | -$115.19M(+18.9%) |
| Mar 2019 | - | -$28.33M(+13.2%) | -$96.85M(+5.2%) |
| Dec 2018 | -$92.08M(+60.9%) | -$25.02M(-8.2%) | -$92.08M(+9.1%) |
| Sep 2018 | - | -$27.25M(+67.7%) | -$84.37M(+20.3%) |
| Jun 2018 | - | -$16.25M(-31.0%) | -$70.11M(+2.1%) |
| Mar 2018 | - | -$23.56M(+36.1%) | -$68.65M(+20.0%) |
| Dec 2017 | -$57.22M(+17.6%) | -$17.31M(+33.2%) | -$57.22M(+35.3%) |
| Sep 2017 | - | -$12.99M(-12.2%) | -$42.28M(+7.4%) |
| Jun 2017 | - | -$14.79M(+22.1%) | -$39.35M(-0.2%) |
| Mar 2017 | - | -$12.12M(+410.9%) | -$39.41M(-19.0%) |
| Dec 2016 | -$48.66M(+28.7%) | -$2.37M(-76.4%) | -$48.66M(-22.9%) |
| Sep 2016 | - | -$10.06M(-32.3%) | -$63.08M(-5.0%) |
| Jun 2016 | - | -$14.86M(-30.4%) | -$66.40M(+46.5%) |
| Mar 2016 | - | -$21.36M(+27.2%) | -$45.33M(+19.9%) |
| Dec 2015 | -$37.82M(-5.9%) | -$16.80M(+25.5%) | -$37.82M(+20.5%) |
| Sep 2015 | - | -$13.38M(-315.6%) | -$31.38M(+23.0%) |
| Jun 2015 | - | $6.21M(-144.8%) | -$25.51M(-43.5%) |
| Mar 2015 | - | -$13.85M(+33.7%) | -$45.15M(+12.3%) |
| Dec 2014 | -$40.19M(+58.7%) | -$10.36M(+37.8%) | -$40.19M(+18.1%) |
| Sep 2014 | - | -$7.51M(-44.0%) | -$34.02M(+2.1%) |
| Jun 2014 | - | -$13.42M(+50.9%) | -$33.32M(+7.8%) |
| Mar 2014 | - | -$8.89M(+112.4%) | -$30.90M(+22.0%) |
| Dec 2013 | -$25.33M(-26.4%) | -$4.19M(-38.5%) | -$25.33M(-18.3%) |
| Sep 2013 | - | -$6.81M(-38.1%) | -$31.02M(-5.3%) |
| Jun 2013 | - | -$11.01M(+230.9%) | -$32.74M(-0.3%) |
| Mar 2013 | - | -$3.33M(-66.3%) | -$32.85M(-4.6%) |
| Dec 2012 | -$34.41M(-35.3%) | -$9.87M(+15.7%) | -$34.41M(-12.1%) |
| Sep 2012 | - | -$8.53M(-23.2%) | -$39.17M(-9.8%) |
| Jun 2012 | - | -$11.12M(+127.2%) | -$43.44M(-6.7%) |
| Mar 2012 | - | -$4.89M(-66.6%) | -$46.57M(-12.4%) |
| Dec 2011 | -$53.17M(+57.1%) | -$14.63M(+14.2%) | -$53.18M(+10.0%) |
| Sep 2011 | - | -$12.80M(-10.1%) | -$48.35M(+3.9%) |
| Jun 2011 | - | -$14.24M(+23.9%) | -$46.54M(+9.2%) |
| Mar 2011 | - | -$11.50M(+17.3%) | -$42.62M(+25.9%) |
| Dec 2010 | -$33.85M(+146.4%) | -$9.80M(-10.8%) | -$33.85M(+277.7%) |
| Sep 2010 | - | -$10.99M(+6.4%) | -$8.96M(+3.4%) |
| Jun 2010 | - | -$10.33M(+278.5%) | -$8.67M(+22.5%) |
| Mar 2010 | - | -$2.73M(-118.1%) | -$7.08M(-48.5%) |
| Dec 2009 | -$13.74M | $15.09M(-241.0%) | -$13.74M(-27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$10.70M(+22.4%) | -$19.02M(+6.3%) |
| Jun 2009 | - | -$8.74M(-6.9%) | -$17.89M(-20.6%) |
| Mar 2009 | - | -$9.39M(-195.7%) | -$22.54M(-17.0%) |
| Dec 2008 | -$27.16M(-15.8%) | $9.80M(-202.4%) | -$27.16M(-32.8%) |
| Sep 2008 | - | -$9.57M(-28.5%) | -$40.40M(-5.4%) |
| Jun 2008 | - | -$13.38M(-4.5%) | -$42.69M(+15.7%) |
| Mar 2008 | - | -$14.02M(+308.9%) | -$36.89M(+54.9%) |
| Dec 2007 | -$32.28M(-31.3%) | -$3.43M(-71.1%) | -$23.81M(-23.5%) |
| Sep 2007 | - | -$11.86M(+56.4%) | -$31.12M(-12.9%) |
| Jun 2007 | - | -$7.58M(+705.9%) | -$35.72M(-8.8%) |
| Mar 2007 | - | -$940.80K(-91.2%) | -$39.15M(-16.7%) |
| Dec 2006 | -$46.98M(+72.9%) | -$10.74M(-34.8%) | -$46.98M(+7.4%) |
| Sep 2006 | - | -$16.46M(+49.4%) | -$43.73M(+24.2%) |
| Jun 2006 | - | -$11.02M(+25.7%) | -$35.20M(+16.9%) |
| Mar 2006 | - | -$8.77M(+17.1%) | -$30.11M(+10.8%) |
| Dec 2005 | -$27.18M(+24.9%) | -$7.49M(-5.5%) | -$27.18M(+8.2%) |
| Sep 2005 | - | -$7.93M(+33.6%) | -$25.12M(+10.9%) |
| Jun 2005 | - | -$5.93M(+1.7%) | -$22.64M(+3.2%) |
| Mar 2005 | - | -$5.83M(+7.4%) | -$21.94M(+0.9%) |
| Dec 2004 | -$21.75M(+59.0%) | -$5.43M(-0.4%) | -$21.75M(+5.8%) |
| Sep 2004 | - | -$5.45M(+4.2%) | -$20.55M(+11.0%) |
| Jun 2004 | - | -$5.23M(-7.3%) | -$18.51M(+12.0%) |
| Mar 2004 | - | -$5.64M(+33.4%) | -$16.53M(+20.9%) |
| Dec 2003 | -$13.68M(-26.9%) | -$4.23M(+24.1%) | -$13.68M(-4.6%) |
| Sep 2003 | - | -$3.41M(+4.8%) | -$14.33M(-0.0%) |
| Jun 2003 | - | -$3.25M(+16.6%) | -$14.34M(-12.2%) |
| Mar 2003 | - | -$2.79M(-42.9%) | -$16.34M(-14.8%) |
| Dec 2002 | -$18.70M(+275.2%) | -$4.88M(+43.0%) | -$19.16M(+13.5%) |
| Sep 2002 | - | -$3.42M(-34.9%) | -$16.88M(+24.3%) |
| Jun 2002 | - | -$5.25M(-6.6%) | -$13.59M(+64.0%) |
| Mar 2002 | - | -$5.62M(+115.6%) | -$8.28M(+58.3%) |
| Dec 2001 | -$4.99M(-49.3%) | -$2.60M(+2088.7%) | -$5.23M(-7.9%) |
| Sep 2001 | - | -$119.00K(-316.4%) | -$5.68M(-24.7%) |
| Jun 2001 | - | $55.00K(-102.1%) | -$7.55M(-24.8%) |
| Mar 2001 | - | -$2.57M(-16.0%) | -$10.04M(+1.6%) |
| Dec 2000 | -$9.83M(+21.4%) | -$3.06M(+54.0%) | -$9.88M(+7.1%) |
| Sep 2000 | - | -$1.98M(-18.5%) | -$9.23M(-6.2%) |
| Jun 2000 | - | -$2.43M(+0.9%) | -$9.85M(+24.3%) |
| Mar 2000 | - | -$2.41M(+0.5%) | -$7.92M(-1.1%) |
| Dec 1999 | -$8.10M(+35.0%) | -$2.40M(-7.7%) | -$8.01M(+8.1%) |
| Sep 1999 | - | -$2.60M(+411.6%) | -$7.41M(+207.6%) |
| Jun 1999 | - | -$508.00K(-79.7%) | -$2.41M(-52.8%) |
| Mar 1999 | - | -$2.50M(+38.9%) | -$5.10M(-12.1%) |
| Dec 1998 | -$6.00M(-51.2%) | -$1.80M(-175.0%) | -$5.80M(-21.6%) |
| Sep 1998 | - | $2.40M(-175.0%) | -$7.40M(-41.3%) |
| Jun 1998 | - | -$3.20M(0.0%) | -$12.60M(+5.9%) |
| Mar 1998 | - | -$3.20M(-5.9%) | -$11.90M(-2.5%) |
| Dec 1997 | -$12.30M(+41.4%) | -$3.40M(+21.4%) | -$12.20M(+1.7%) |
| Sep 1997 | - | -$2.80M(+12.0%) | -$12.00M(+3.4%) |
| Jun 1997 | - | -$2.50M(-28.6%) | -$11.60M(+11.5%) |
| Mar 1997 | - | -$3.50M(+9.4%) | -$10.40M(+18.2%) |
| Dec 1996 | -$8.70M(-4.4%) | -$3.20M(+33.3%) | -$8.80M(+11.4%) |
| Sep 1996 | - | -$2.40M(+84.6%) | -$7.90M(+3.9%) |
| Jun 1996 | - | -$1.30M(-31.6%) | -$7.60M(-5.0%) |
| Mar 1996 | - | -$1.90M(-17.4%) | -$8.00M(-11.1%) |
| Dec 1995 | -$9.10M(+33.8%) | -$2.30M(+9.5%) | -$9.00M(+4.7%) |
| Sep 1995 | - | -$2.10M(+23.5%) | -$8.60M(+4.9%) |
| Jun 1995 | - | -$1.70M(-41.4%) | -$8.20M(-2.4%) |
| Mar 1995 | - | -$2.90M(+52.6%) | -$8.40M(+20.0%) |
| Dec 1994 | -$6.80M | -$1.90M(+11.8%) | -$7.00M(+37.3%) |
| Sep 1994 | - | -$1.70M(-10.5%) | -$5.10M(+50.0%) |
| Jun 1994 | - | -$1.90M(+26.7%) | -$3.40M(+126.7%) |
| Mar 1994 | - | -$1.50M | -$1.50M |
FAQ
- What is BioCryst Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual EBIT year-on-year change?
- What is BioCryst Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly EBIT year-on-year change?
- What is BioCryst Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM EBIT year-on-year change?
What is BioCryst Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of BCRX is $11.56M
What is the all time high annual EBIT for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual earnings before interest & taxes is $11.56M
What is BioCryst Pharmaceuticals annual EBIT year-on-year change?
Over the past year, BCRX annual earnings before interest & taxes has changed by +$129.55M (+109.80%)
What is BioCryst Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of BCRX is $24.25M
What is the all time high quarterly EBIT for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly earnings before interest & taxes is $24.25M
What is BioCryst Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, BCRX quarterly earnings before interest & taxes has changed by +$34.76M (+330.80%)
What is BioCryst Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of BCRX is $46.32M
What is the all time high TTM EBIT for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM earnings before interest & taxes is $46.32M
What is BioCryst Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, BCRX TTM earnings before interest & taxes has changed by +$149.55M (+144.87%)